Literature DB >> 32710608

MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatment.

Donald W Kufe1.   

Abstract

Chronic inflammation is a highly prevalent consequence of changes in environmental and lifestyle factors that contribute to the development of cancer. The basis for this critical association has largely remained unclear. The MUC1 gene evolved in mammals to protect epithelia from the external environment. The MUC1-C subunit promotes responses found in wound healing and cancer. MUC1-C induces EMT, epigenetic reprogramming, dedifferentiation and pluripotency factor expression, which when prolonged in chronic inflammation promote cancer progression. As discussed in this review, MUC1-C also drives drug resistance and immune evasion, and is an important target for cancer therapeutics now under development.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32710608      PMCID: PMC7513951          DOI: 10.1093/carcin/bgaa082

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  128 in total

1.  MUC1 membrane trafficking: protocols for assessing biosynthetic delivery, endocytosis, recycling, and release through exosomes.

Authors:  Franz-Georg Hanisch; Carol L Kinlough; Simon Staubach; Rebecca P Hughey
Journal:  Methods Mol Biol       Date:  2012

2.  MUC1-C drives stemness in progression of colitis to colorectal cancer.

Authors:  Wei Li; Ning Zhang; Caining Jin; Mark D Long; Hasan Rajabi; Yota Yasumizu; Atsushi Fushimi; Nami Yamashita; Masayuki Hagiwara; Rongbin Zheng; Jin Wang; Ling Kui; Harpal Singh; Surender Kharbanda; Qiang Hu; Song Liu; Donald Kufe
Journal:  JCI Insight       Date:  2020-06-18

Review 3.  Role of MTA1 in cancer progression and metastasis.

Authors:  Nirmalya Sen; Bin Gui; Rakesh Kumar
Journal:  Cancer Metastasis Rev       Date:  2014-12       Impact factor: 9.264

4.  Mucin 1 C-terminal subunit oncoprotein is a target for small-molecule inhibitors.

Authors:  Yongchun Zhou; Hasan Rajabi; Donald Kufe
Journal:  Mol Pharmacol       Date:  2011-02-23       Impact factor: 4.436

Review 5.  Cellular plasticity and the neuroendocrine phenotype in prostate cancer.

Authors:  Alastair H Davies; Himisha Beltran; Amina Zoubeidi
Journal:  Nat Rev Urol       Date:  2018-02-20       Impact factor: 14.432

6.  MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells.

Authors:  Tsuyoshi Hata; Hasan Rajabi; Hidekazu Takahashi; Yota Yasumizu; Wei Li; Caining Jin; Mark D Long; Qiang Hu; Song Liu; Atsushi Fushimi; Nami Yamashita; Ling Kui; Deli Hong; Masaaki Yamamoto; Masaaki Miyo; Masayuki Hiraki; Takahiro Maeda; Yozo Suzuki; Mehmet K Samur; Donald Kufe
Journal:  Cancer Res       Date:  2019-09-13       Impact factor: 12.701

7.  Oncogenic MUC1-C promotes tamoxifen resistance in human breast cancer.

Authors:  Akriti Kharbanda; Hasan Rajabi; Caining Jin; Deepak Raina; Donald Kufe
Journal:  Mol Cancer Res       Date:  2013-03-28       Impact factor: 5.852

8.  MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients.

Authors:  Dhara M MacDermed; Nikolai N Khodarev; Sean P Pitroda; Darrin C Edwards; Charles A Pelizzari; Lei Huang; Donald W Kufe; Ralph R Weichselbaum
Journal:  BMC Med Genomics       Date:  2010-05-06       Impact factor: 3.063

Review 9.  MUC1 in hematological malignancies.

Authors:  Dina Stroopinsky; Donald Kufe; David Avigan
Journal:  Leuk Lymphoma       Date:  2016-06-27

Review 10.  Cancer as an overhealing wound: an old hypothesis revisited.

Authors:  Matthias Schäfer; Sabine Werner
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07-16       Impact factor: 94.444

View more
  19 in total

1.  MUC1 triggers lineage plasticity of Her2 positive mammary tumors.

Authors:  Zhi Pang; Xinran Dong; Huayun Deng; Chengzhi Wang; Xiaodong Liao; Chunhua Liao; Yahui Liao; Weidong Tian; Jinke Cheng; Guoqiang Chen; Haiying Yi; Lei Huang
Journal:  Oncogene       Date:  2022-04-23       Impact factor: 9.867

2.  MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells.

Authors:  Atrayee Bhattacharya; Atsushi Fushimi; Nami Yamashita; Masayuki Hagiwara; Yoshihiro Morimoto; Hasan Rajabi; Mark D Long; Maha Abdulla; Rehan Ahmad; Kelly Street; Song Liu; Tao Liu; Donald Kufe
Journal:  Mol Cancer Res       Date:  2022-04-01       Impact factor: 5.852

3.  Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non-neuroendocrine Small Cell Lung Cancer.

Authors:  Atsushi Fushimi; Yoshihiro Morimoto; Satoshi Ishikawa; Nami Yamashita; Atrayee Bhattacharya; Tatsuaki Daimon; Hasan Rajabi; Caining Jin; Masayuki Hagiwara; Yota Yasumizu; Zhou Luan; Wenhao Suo; Kwok-Kin Wong; Henry Withers; Song Liu; Mark D Long; Donald Kufe
Journal:  Mol Cancer Res       Date:  2022-09-02       Impact factor: 6.333

4.  WWP1 targeting MUC1 for ubiquitin-mediated lysosomal degradation to suppress carcinogenesis.

Authors:  Chunhua Liao; Liping Yu; Zhi Pang; Huayun Deng; Xiaodong Liao; Shengze Li; Jinke Cheng; Min Qi; Guoqiang Chen; Lei Huang
Journal:  Signal Transduct Target Ther       Date:  2021-08-18

5.  MUC1-C Activates the BAF (mSWI/SNF) Complex in Prostate Cancer Stem Cells.

Authors:  Masayuki Hagiwara; Yota Yasumizu; Nami Yamashita; Hasan Rajabi; Atsushi Fushimi; Mark D Long; Wei Li; Atrayee Bhattacharya; Rehan Ahmad; Mototsugu Oya; Song Liu; Donald Kufe
Journal:  Cancer Res       Date:  2020-12-15       Impact factor: 13.312

6.  MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer.

Authors:  Nami Yamashita; Mark Long; Atsushi Fushimi; Masaaki Yamamoto; Tsuyoshi Hata; Masayuki Hagiwara; Atrayee Bhattacharya; Qiang Hu; Kwok-Kin Wong; Song Liu; Donald Kufe
Journal:  J Immunother Cancer       Date:  2021-01       Impact factor: 13.751

7.  Asynchrony of Apical Polarization, Luminogenesis, and Functional Differentiation in the Developing Thyroid Gland.

Authors:  Ellen Johansson; Shawn Liang; Carmen Moccia; Therese Carlsson; Daniel Andersson; Henrik Fagman; Mikael Nilsson
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-17       Impact factor: 5.555

Review 8.  Novel insights into the roles and therapeutic implications of MUC1 oncoprotein via regulating proteins and non-coding RNAs in cancer.

Authors:  Wei Li; Yineng Han; Chenmin Sun; Xue Li; Junhua Zheng; Jianping Che; Xudong Yao; Donald Kufe
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.556

Review 9.  Breast Cancer Tumor Microenvironment and Molecular Aberrations Hijack Tumoricidal Immunity.

Authors:  Huey-Jen Lin; Yingguang Liu; Denene Lofland; Jiayuh Lin
Journal:  Cancers (Basel)       Date:  2022-01-07       Impact factor: 6.639

10.  MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells.

Authors:  Masayuki Hagiwara; Atsushi Fushimi; Nami Yamashita; Atrayee Bhattacharya; Hasan Rajabi; Mark D Long; Yota Yasumizu; Mototsugu Oya; Song Liu; Donald Kufe
Journal:  Oncogene       Date:  2021-06-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.